TAG:
cap
Why DIANON Sale Alters Anatomic Path Market
By Robert Michel | From the Volume IX No. 16 – November 18, 2002 Issue
CEO SUMMARY: By acquiring DIANON Systems, LabCorp raises the level of competition for tissue specimens originating in physicians’ offices. LabCorp’s acquisition is also a validation of predictions that cancer diagnostics will be a high-growth segment of laboratory medicine. Anatomic p…
“Direct-to-Consumer” Ad Runs in New York Times
By Robert Michel | From the Volume IX No. 16 – November 18, 2002 Issue
CEO SUMMARY: Two pioneering advertising campaigns launched in September. Both Myriad Genetics and IMPATH targeted consumers with advertisements about diagnostic testing. In each case, the most vocal response to the advertising came from within the medical community. Within the pathology p…
Hospitals in Michigan Build Unique Shared Lab
By Robert Michel | From the Volume IX No. 15 – October 28, 2002 Issue
CEO SUMMARY: This operational model for a collaborative regional laboratory organization makes “profit” irrelevant. Serving 30 hospitals in four Midwestern states, Michigan Co-Tenancy Laboratories is consistently expanding lab testing services, lowering costs, and emphasizing the labo…
Major Changes at Dade Behring Soon to Be Visible In Lab Market
By Robert Michel | From the Volume IX No. 15 – October 28, 2002 Issue
Its recent financial restructuring now complete, Dade Behring prepares a “brand building” campaign CEO SUMMARY: Dade Behring is poised to become a tough and high-profile competitor in the laboratory diagnostics marketplace. Earlier this month,…
HCA, Tenet , Specialty Labs
By Robert Michel | From the Volume IX No. 15 – October 28, 2002 Issue
HCA WANTS TO BUY HEALTH MIDWEST FOR $1.25 BILLION FOR-PROFIT HOSPITAL BEHEMOTH HCA Inc. announced an agreement in principal to acquire Health Midwest, a 14-hospital system based in Kansas City, Missouri. Subject to further negotiations and due diligence, H…
Disease Management Relies On Lab Testing
By Robert Michel | From the Volume IX No. 15 – October 28, 2002 Issue
CEO SUMMARY: Predictions are that 30% of large corporations will offer disease management programs for their employees by the end of next year. Disease management seems to be the next form of managed care, where prevention and early detection are the primary goals. Laboratories should be …
San Fran Bay Hospitals Jointly Fund MT Training
By Robert Michel | From the Volume IX No. 14 – October 7, 2002 Issue
CEO SUMMARY: Laboratory administrators in 15 Bay-area hospitals created their own plan to expand the available pool of trained med techs. Using a detailed analysis of the demographics of the problem, along with a financial analysis of non-action, they convinced CEOs of 15 hospitals to inv…
Quest & LabCorp Encounter Different Business Hurdles
By Robert Michel | From the Volume IX No. 14 – October 7, 2002 Issue
IT’S BEEN TOUGH SLEDDING in recent months for both Laboratory Corporation of America and Quest Diagnostics Incorporated. THE DARK REPORT believes there may be significance in these developments. Both national labs find themselves confronted with unexpected obstacl…
Removing Lab Players From the Chessboard
By R. Lewis Dark | From the Volume IX No. 13 – September 16, 2002 Issue
IN 1997-98, CEO Ken Freeman of Quest Diagnostics Incorporated made a keen insight about the commercial lab marketplace. At that time the three blood brothers—Laboratory Corporation of America, Quest Diagnostics, and SmithKline Beecham Clinical Laboratories…
Esoterix Ready to Launch National Marketing Blitz
By Robert Michel | From the Volume IX No. 13 – September 16, 2002 Issue
CEO SUMMARY: It was 1995 when several specialty testing lab companies were acquired by a new company called Esoterix. Immediately the lab industry viewed Esoterix as a “put-together” lab company. However, since 2000, executives at Esoterix have invested $50 million to integrate operat…
CURRENT ISSUE
Volume XXXIII, No. 4 – March 23, 2026
A federal court ruling has established a safe harbor for clinical labs when they run tests ordered by physicians. Lab leaders should examine this briefing for pitfalls. Also, it turns out that providers may be ordering inappropriate vitamin D tests, according to one expert.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized